Bing

Trade-Ideas LLC identified Sanofi ( SNY) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Sanofi as such a stock due to the following factors: SNY has an average dollar-volume (as ...
The Street · 8/26/2015
Thermo Fisher Scientific Inc (TMO): TMO stock is down 1.2% today. Johnson & Johnson (JNJ): JNJ stock is down 1.2% today. Sanofi-Aventis Sa (SNY): SNY stock is down 1.1% today. Tornier N.V. (TRNX): TRNX stock is down 1.1% today. For more …
Investor Place · 1 day ago
Since I doubt that this antibody is figuring much if at all in the Street's valuation models for REGN, the possibility of a welcome upside surprise is something that I do consider in evaluating this stock. REGN has announced what it and SNY have described ...
Seeking Alpha · 8/26/2015
biotech stocks
More from Bing News
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report REGENERON PHARM (REGN): Free Stock Analysis Report SANOFI-AVENTIS (SNY): Free Stock Analysis Report
Yahoo Finance · 8/27/2015
Lung Cancer
The FDA approved Amgen's (NASDAQ:AMGN) cholesterol drug Repatha late Thursday, giving it a similar label to a recently approved rival from Regeneron (NASDAQ:REGN) and Sanofi (NYSE:SNY), but a slightly …
Investors Business Daily · ByAmy Reeves · 8/27/2015
In the past three months, the company’s shares declined steeply twice, and the stock is expected to see another drop toward ... and Sanofi SA (ADR) (NYSE:SNY). Regeneron secured approval for Praluent on July 24 …
bidnessetc.com · 8/26/2015
Esperion
Incyte Corp (INCY)- The company’s stocks lost 2.0 pct. Emergent Biosolutions (EBS)- The company’s shares shed 1.8 pct. Dr. Reddy’s Laboratories Ltd (RDY)- The company’s shares dropped 1.7 pct.
Fx Pips · 8/17/2015
who point to AbbVie (ABBV), Johnson & Johnson (JNJ), Novartis (NVS), and Sanofi (SNY) as appearing undervalued “on most valuations metrics.” They explain: The aggregate implied discount rate [for Major Pharma …
Barron's · 8/18/2015
This analysis was compiled based on yesterday's trading activity as we search for stocks that have could possible underperform ... follows with a loss of 1.67% and Sanofi-Aventis (NYSE:SNY) rounds out the bottom five with a loss of 1.46%.
Financial News Network Online · ByMallory Stone · 8/17/2015
Pharmaceuticals Industry
according to research firm CoStar Group Inc. Recent leases at the building include the digital marketing firm MediaMath Inc., stock-selling startup IEX Group and investment-research company Morningstar Inc. SNY spokesman Kevin Sornatale and Bud …
Bloomberg · ByDavid M Levitt andScott Soshnick · 8/20/2015